Dementias Active Not Recruiting Phase 2 / 3 Trials for Solanezumab (DB11756)

Also known as: Dementia / Dementia NOS / Amentia

DBCOND0060453 (Dementias)Active Not Recruiting2 / 3 IdentifierTitlePurposeDrugs
NCT01760005Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.Treatment